Cargando…

Ketamine treatment for depression: a review

This manuscript reviews the clinical evidence regarding single-dose intravenous (IV) administration of the novel glutamatergic modulator racemic (R,S)-ketamine (hereafter referred to as ketamine) as well as its S-enantiomer, intranasal esketamine, for the treatment of major depressive disorder (MDD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yavi, Mani, Lee, Holim, Henter, Ioline D., Park, Lawrence T., Zarate, Carlos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010394/ https://www.ncbi.nlm.nih.gov/pubmed/35509843 http://dx.doi.org/10.1007/s44192-022-00012-3

Ejemplares similares

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
por: Duncan, Wallace C, et al.
Publicado: (2018)

Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depressive Disorder
por: Kadriu, Bashkim, et al.
Publicado: (2017)

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018)

Ketamine for Bipolar Depression: A Systematic Review
por: Bahji, Anees, et al.
Publicado: (2021)

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2010)

Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2018)

Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2019)

A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants
por: Alitalo, Okko, et al.
Publicado: (2021)

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2023)

Ketamine for the treatment of major depression: a systematic review and meta-analysis
por: Nikolin, Stevan, et al.
Publicado: (2023)

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
por: Moaddel, Ruin, et al.
Publicado: (2022)

Ketamine Has Distinct Electrophysiological and Behavioral Effects in Depressed and Healthy Subjects
por: Nugent, Allison C., et al.
Publicado: (2018)

New Therapeutic Targets for Mood Disorders
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2010)

Exome-wide association study of treatment-resistant depression suggests novel treatment targets
por: Shah, Shrey B., et al.
Publicado: (2023)

Ketamine and depression: a narrative review
por: Corriger, Alexandrine, et al.
Publicado: (2019)

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
por: Jawad, Muhammad Youshay, et al.
Publicado: (2023)

Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Kowalczyk, Mateusz, et al.
Publicado: (2021)

Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression
por: Fagerholm, Erik D., et al.
Publicado: (2021)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

The neurotrophic and neuroprotective effects of psychotropic agents
por: Hunsberger, Joshua, et al.
Publicado: (2009)

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
por: Park, Lawrence, et al.
Publicado: (2018)

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
por: Mohammad Shehata, Islam, et al.
Publicado: (2022)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Ketamine: a new chapter in antidepressant development
por: Zarate, Carlos A.
Publicado: (2020)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
por: Lally, N, et al.
Publicado: (2014)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
por: Mkrtchian, Anahit, et al.
Publicado: (2020)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

The Kynurenine Pathway and Bipolar Disorder: Intersection of the Monoaminergic and Glutamatergic Systems and Immune Response
por: Kadriu, Bashkim, et al.
Publicado: (2019)

Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
por: Borsellino, Philip, et al.
Publicado: (2023)

Effects of stress on endophenotypes of suicide across species: A role for ketamine in risk mitigation
por: Lamontagne, Steven J., et al.
Publicado: (2022)

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
por: Veraart, Jolien K E, et al.
Publicado: (2021)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
por: Reed, Jessica L., et al.
Publicado: (2018)

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
por: Xu, Annie J., et al.
Publicado: (2015)

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
por: Richards, Erica M., et al.
Publicado: (2018)

Efficacy and safety of ketamine for the treatment of depressive symptoms in palliative care: a systematic review
por: Barbosa, Matheus Ghossain, et al.
Publicado: (2023)

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k58amh5i0i3i0n3i5hoh8cigav